The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -101,146 |
| Imputed interest - related parties | 9,154 |
| Liability forgiveness | 62,032 |
| Security deposit | 4,600 |
| Prepaid expenses | 10,000 |
| Accounts payable and accrued expenses | -36,878 |
| Net cash used in operating activities | -196,302 |
| Advances from related parties | 199,924 |
| Net cash provided by financing activities | 199,924 |
| Net change in cash | 3,622 |
| Cash and cash equivalents at beginning of period | 476 |
| Cash and cash equivalents at end of period | 4,098 |
ACRO BIOMEDICAL CO., LTD. (ACBM)
ACRO BIOMEDICAL CO., LTD. (ACBM)